AGN - Allergan beats Q1 consensus; ups guidance May, 07 2019 08:50 AM Allergan plc Allergan (AGN) Q1 results: Revenues: $3,597.1M (-2.0%); US Specialized Therapeutics: $1,542.9M (-2.8%); US General Medicine: $1,249.9M (+2.1%); International: $801.5M (-7.2%).More news on: Allergan plc, Healthcare stocks news, Earnings news and commentary, Read more ...